US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.89

+1.163.07%

Post-market: 39.000.1100+0.28%19:55 EDT

Volume:1.75M

Turnover:68.13M

Market Cap:5.23B

PE:-11.17

High:39.37

Open:37.73

Low:37.73

Close:37.73

52wk High:49.70

52wk Low:8.77

Shares:134.37M

Float Shares:131.11M

Volume Ratio:1.28

T/O Rate:1.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.69

PE(LYR):-18.88

Loading ...

Overview Company News Filings

Definium Therapeutics (DFTX) Could Be 30% Overvalued After New GAD Study

Simply Wall St.

Will New GAD Treatment Persistence Data Change Definium Therapeutics' (DFTX) Unmet‑Need Narrative?

Simply Wall St.

Movement Alert｜Definium Therapeutics Rises 5.13% in Regular Trading, Trading at $45.845

Definium Therapeutics announces results from healthcare claims study in GAD

Definium Says Claims Study Finds High GAD Drug Discontinuation, Switching Rates

Movement Alert｜Definium Therapeutics Falls 5.44% in Regular Trading, Trading at $44.45

Movement Alert｜Definium Therapeutics Falls 5.06% in Regular Trading, Trading at $45.96

Movement Alert｜Definium Therapeutics Rises 5.09% in Regular Trading, Phase 3 Clinical Success and Major Financing Boost Market Confidence

Definium Therapeutics price target raised to $60 from $30 at Stifel

Definium Therapeutics Inc : Stifel Raises Target Price to $60 from $30

THOMSON REUTERS

Definium Therapeutics (DFTX) Following Russell Index Removal And The Fair Value Debate

Simply Wall St.

Definium Therapeutics Issues Inducement Stock Options for 169,740 Shares to New Hires

LSD Therapy Biotech Definium Fends Off Trade-secret Lawsuit

Movement Alert｜Definium Therapeutics Falls 5.02% in Regular Trading, Trading at $44.52

Definium Therapeutics is Maintained at Buy by Canaccord Genuity

Movement Alert｜Definium Therapeutics Rises 5.04% in Regular Trading, Buoyed by Phase 3 Success and $805M Offering Completion

Wall Street Analysts Are Bullish on Top Healthcare Picks

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

THOMSON REUTERS

Definium Therapeutics Closes USD 805 Million Upsized Follow-on Offering at USD 34 Per Share

Movement Alert｜Definium Therapeutics Rises 9.07% in Regular Trading, Phase 3 EMERGE Study Hits Primary Endpoint and $700 Million Offering Priced

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/DFTX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.89,"timestamp":1789156800000,"preClose":37.73,"halted":0,"volume":1754315,"hourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"delay":0,"changeRate":0.03074476543864309,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":1.16,"latestTime":"09-11 16:00:00 EDT","open":37.73,"high":39.37,"low":37.73,"amount":68131498.355375,"amplitude":0.043467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.73,"preHourTrading":{"tag":"盘前","latestPrice":37.9852,"preClose":37.73,"latestTime":"09:18 EDT","volume":4465,"amount":169832.67781,"timestamp":1789132705128,"change":0.2552,"changeRate":0.006764,"amplitude":0.020448},"postHourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"volumeRatio":1.2818231822401762,"impliedVol":1.3321,"impliedVolPercentile":0.8963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.2818231822401762,"shares":134366950,"dividePrice":0,"high":39.37,"amplitude":0.043467,"preClose":37.73,"low":37.73,"week52Low":8.7732,"pbRate":"5.69","week52High":49.7,"institutionHeld":0,"latestPrice":38.89,"eps":-3.482311,"divideRate":0,"volume":1754315,"delay":0,"ttmEps":-3.482311,"open":37.73,"prevYearClose":13.39,"prevWeekClose":38.09,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":38,"twentyDayClose":43.9,"sixtyDayClose":24.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-11","current":-11.167871,"percent":0.337423,"low":-27.074722,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"high":-8.802064,"avg":-13.932943,"sd":5.402262,"marketCap":5069665023},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023}],"updateTime":1789221852511},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651111494","title":"Definium Therapeutics (DFTX) Could Be 30% Overvalued After New GAD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111494","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111494?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:27","pubTimestamp":1784154476,"startTime":"0","endTime":"0","summary":"What the new GAD study tells investors about Definium Therapeutics stock\nDefinium Therapeutics (DFTX) has put fresh clinical needs in the spotlight with a large healthcare claims study in CNS Spectrums showing many generalized anxiety disorder patients discontinuing or switching treatment far earlier than guidelines suggest.\nFor you as an investor, the findings matter because they quantify how often real world patients move away from current generalized anxiety disorder therapies or...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651486358","title":"Will New GAD Treatment Persistence Data Change Definium Therapeutics' (DFTX) Unmet‑Need Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651486358","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651486358?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:43","pubTimestamp":1784054639,"startTime":"0","endTime":"0","summary":"Definium Therapeutics recently reported results from a large U.S. healthcare claims study, published in CNS Spectrums, examining real‑world pharmacotherapy patterns in adults with generalized anxiety disorder between 2020 and 2024.\nThe analysis revealed frequent early discontinuation, rapid switching, and prolonged gaps in care, underscoring substantial unmet need and limited durability of benefit with current GAD treatment options.\nNext, we will explore how this evidence of high...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126761817","title":"Movement Alert｜Definium Therapeutics Rises 5.13% in Regular Trading, Trading at $45.845","url":"https://stock-news.laohu8.com/highlight/detail?id=1126761817","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126761817?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:38","pubTimestamp":1784047137,"startTime":"0","endTime":"0","summary":"On July 14, Definium Therapeutics rose 5.13% in regular trading, trading at $45.845 USD/share, with Turnover of $23.838 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651965170","title":"Definium Therapeutics announces results from healthcare claims study in GAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2651965170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651965170?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:11","pubTimestamp":1784027482,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD pati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","NOBL","BK4585","BK4588","CGCV","VHT","DFTX","BK4007","TCAF","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651779631","title":"Definium Says Claims Study Finds High GAD Drug Discontinuation, Switching Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2651779631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651779631?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026838,"startTime":"0","endTime":"0","summary":"Definium says claims study finds high GAD drug discontinuation, switching ratesDefinium Therapeutics reported results from a healthcare claims study in CNS Spectrums showing high switching, discontinu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3nF15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113461683","title":"Movement Alert｜Definium Therapeutics Falls 5.44% in Regular Trading, Trading at $44.45","url":"https://stock-news.laohu8.com/highlight/detail?id=1113461683","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113461683?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:22","pubTimestamp":1783952568,"startTime":"0","endTime":"0","summary":"On July 13, Definium Therapeutics fell 5.44% in regular trading, trading at $44.45 USD/share, with Turnover of $13.26 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171789885","title":"Movement Alert｜Definium Therapeutics Falls 5.06% in Regular Trading, Trading at $45.96","url":"https://stock-news.laohu8.com/highlight/detail?id=1171789885","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171789885?lang=en_us&edition=fundamental","pubTime":"2026-07-10 21:52","pubTimestamp":1783691561,"startTime":"0","endTime":"0","summary":"On July 10, Definium Therapeutics fell 5.06% in regular trading, trading at $45.96 USD/share, with Turnover of $9.66 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192883916","title":"Movement Alert｜Definium Therapeutics Rises 5.09% in Regular Trading, Phase 3 Clinical Success and Major Financing Boost Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1192883916","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192883916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:54","pubTimestamp":1783612460,"startTime":"0","endTime":"0","summary":"On July 9, Definium Therapeutics rose 5.09% in regular trading, trading at $47.34 per share with turnover of $67.50 million.The rally continues to be driven by the companys core product DT120 orally...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649998253","title":"Definium Therapeutics price target raised to $60 from $30 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649998253?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:11","pubTimestamp":1783509077,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Definium Therapeutics (DFTX) to $60 from $30 and keeps a Buy rating on the shares. Better-than-expected MD...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-30-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-30-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649607819","title":"Definium Therapeutics Inc : Stifel Raises Target Price to $60 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2649607819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649607819?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:58","pubTimestamp":1783508324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649529958","title":"Definium Therapeutics (DFTX) Following Russell Index Removal And The Fair Value Debate","url":"https://stock-news.laohu8.com/highlight/detail?id=2649529958","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649529958?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:42","pubTimestamp":1783456965,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has attracted fresh attention after being removed from several Russell indexes, a shift that can influence index linked trading, liquidity, and how some investors view the stock.\nSee our latest analysis for Definium Therapeutics.\nDespite the index removals and recent inducement grants, Definium Therapeutics has seen strong momentum build over recent months, with a 30 day share price return of 88.24%, a 90 day share price return of 115.40% and a year to date share...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679972","title":"Definium Therapeutics Issues Inducement Stock Options for 169,740 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679972","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679972?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368080,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 169,740 shares to new hiresDefinium Therapeutics issued inducement stock options covering 169,740 common shares to eight newly hired non-execu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL72SgMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648547239","title":"LSD Therapy Biotech Definium Fends Off Trade-secret Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2648547239","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648547239?lang=en_us&edition=fundamental","pubTime":"2026-07-02 00:51","pubTimestamp":1782924663,"startTime":"0","endTime":"0","summary":"LSD therapy biotech Definium fends off trade-secret lawsuitJuly 1 (Reuters)-Psychedelic therapy developer Definium TherapeuticsDFTX.Oconvinced a federal judge in Delaware on Wednesday to dismiss a law","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL6N43312L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110488888","title":"Movement Alert｜Definium Therapeutics Falls 5.02% in Regular Trading, Trading at $44.52","url":"https://stock-news.laohu8.com/highlight/detail?id=1110488888","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110488888?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:51","pubTimestamp":1782921060,"startTime":"0","endTime":"0","summary":"On July 1, Definium Therapeutics fell 5.02% in regular trading, trading at $44.52 USD/share, with Turnover of $43.21 million.Within the Pharmacy sector where Definium Therapeutics belongs, among...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647550271","title":"Definium Therapeutics is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2647550271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647550271?lang=en_us&edition=fundamental","pubTime":"2026-06-30 23:34","pubTimestamp":1782833640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJune 30, 2026 11:34 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121673904","title":"Movement Alert｜Definium Therapeutics Rises 5.04% in Regular Trading, Buoyed by Phase 3 Success and $805M Offering Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1121673904","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121673904?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:04","pubTimestamp":1782828274,"startTime":"0","endTime":"0","summary":"On June 30, Definium Therapeutics rose 5.04% in regular trading, trading at $48.63 per share, with turnover of $22.16 million. The rally follows a cluster of positive catalysts in recent sessions.On...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646397771","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2646397771","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646397771?lang=en_us&edition=fundamental","pubTime":"2026-06-27 22:30","pubTimestamp":1782570614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Definium Therapeutics (DFTX) and Eledon Pharmaceutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-236?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-236?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385769","title":"Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385769?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:24","pubTimestamp":1782419085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646129385","title":"Definium Therapeutics Closes USD 805 Million Upsized Follow-on Offering at USD 34 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646129385","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646129385?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:15","pubTimestamp":1782418541,"startTime":"0","endTime":"0","summary":"Definium Therapeutics closes USD 805 million upsized follow-on offering at USD 34 per shareDefinium Therapeutics closed an upsized underwritten public offering of 23,676,471 common shares at USD 34 pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDLcfdgfY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100061988","title":"Movement Alert｜Definium Therapeutics Rises 9.07% in Regular Trading, Phase 3 EMERGE Study Hits Primary Endpoint and $700 Million Offering Priced","url":"https://stock-news.laohu8.com/highlight/detail?id=1100061988","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100061988?lang=en_us&edition=fundamental","pubTime":"2026-06-25 22:26","pubTimestamp":1782397592,"startTime":"0","endTime":"0","summary":"On June 25, Definium Therapeutics rose 9.07% in regular trading, trading at $45.455/share, with turnover of approximately $98.63 million. The stock continued its momentum driven by multiple positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}